Excellent midsize pharma: opiniones de empleados con el puesto de Director en SpringWorks Therapeutics

5,0
23 jul 2025
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

Remote, independent work; dedicated coworkers

Desventajas

Resources as expected for midsize (capabilities/amenities of large pharma are not available)

Echa un vistazo a otras opiniones sobre SpringWorks Therapeutics.

5,0
1 feb 2026
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

The culture- hype is real. Hands down, best culture I’ve ever worked in. Lets hope EMDS/ Merck KGaA doesn’t ruin it.

Desventajas

The acquisition has been tough. Feels like we’ve joined a sinking ship. A lot of meetings, but real work doesn’t get done.

4,0
15 abr 2026
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

Innovative, robust leadership, community values

Desventajas

Post merger confusion led to more problems in daily workflows

Ver opiniones por: Útil|Valoración|Fecha|Todo